Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Feasibility of Incorporating Psychosocial Oncology During Neoadjuvant Therapy for Patients With Pancreatic Cancer

NCT07124611 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT07124611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07124611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Feasibility of Incorporating Psychosocial Oncology During Neoadjuvant Therapy for Patients With Pancreatic Cancer
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
December 22, 2025
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized pancreatic ductal adenocarcinoma, stage 0 pancreatic cancer ajcc v8, stage i pancreatic cancer ajcc v8, stage iia pancreatic cancer ajcc v8